Table 1 Demographical information for HC, DSZ and NDSZ in Mega and Meta-Analysis samples; Clinical information for DSZ and NDSZ patients in the Mega-Analysis sample.

From: Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses

 

HC

DSZ

ND-SZ

t, F or χ2

df

p

Meta-Analysis

 Age (years), Mean (SD)

33.51 (13)

37.73 (13.1)

37.2 (12.2)

16.17

21561

<0.001*

 Males, n (%)

546 (54)

110 (67)

234 (62)

15.64

2

<0.001*

Mega-Analysis

 Age (years), Mean (SD)

34.5 (12.5)

36.5 (12.5)

35.7 (11.6)

1.74

2941

0.175

 Males, n (%)

272 (43)

93 (80)

160 (63)

51.4

2

<0.001*

 Duration of illness (Years), Mean (SD)

–

13.8 (12.6)

11.9 (11.7)

1.09

1220

0.298

 Chlorpromazine equivalents, Mean (SD)

–

404.5 (414.4)

390.8 (454.2)

0.055

1266

0.814

 PANSS_Pos, Mean (SD)

–

13.6 (5.2)

18 (6.9)

36.7

1367

<0.001*

 PANSS_Neg, Mean (SD)

–

21 (7.5)

16.2 (7)

34.7

1367

<0.001*

 PANSS_Gen, Mean (SD)

–

29.7 (10)

37.5 (12.6)

33.8

1367

<0.001*

  1. df degrees of freedom, SD standard deviation, PANSS_Pos positive symptoms subscale from Positive and Negative Symptoms Scale, PANSS_Neg negative symptoms subscale from Positive and Negative Symptoms Scale, PANSS_Gen general symptoms subscale from Positive and Negative Symptoms Scale, Type of antipsychotic Treatment: T Typical, A Atypical, B Both, N Nothing.
  2. *Statistically significant differences at p < 0.05.
Back to article page